4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-14-059642
Director bought 237,500 shares at $15.00 ($3,562,500)
- Director acquired 3,330,938 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Apple Tree Partners II - Annex, L.P. Director | 2014-09-22 | Conversion | +3,330,938 | 3,330,938 | D | ||
| Apple Tree Partners II - Annex, L.P. Director | 2014-09-22 | Purchase | +237,500 | $15.00 | $3,562,500 | 3,568,438 | D |
| Derivatives | |||||||
| Apple Tree Partners II - Annex, L.P. Director | 2014-09-22 | Conversion · Series D-3 Preferred Stock | −10,675,613 | 0 | D | ||
| Apple Tree Partners II - Annex, L.P. Director | 2014-09-22 | Conversion · Series E Preferred Stock | −24,199,308 | 0 | D | ||
| Open-market purchases · 237,500 sh · avg $15.00 · $3,562,500 | |||||||
Loading xslF345X03/doc4.xml…